D-myo-Inositol 1,3,5-Trisphosphate Hexasodium salt

D-myo-Inositol 1,3,5-Trisphosphate Hexasodium salt, abbreviated as Ins(1,3,5)P3, plays a crucial role in cellular signaling pathways, particularly in intracellular calcium release. Its mechanism of action involves binding to specific receptors on the endoplasmic reticulum (ER) membrane, leading to the release of calcium ions from ER stores into the cytoplasm. This release triggers a cascade of downstream signaling events, regulating various cellular processes such as muscle contraction, secretion, cell proliferation, and gene expression. Ins(1,3,5)P3 is generated from phosphatidylinositol 4,5-bisphosphate (PIP2) via the action of phospholipase C (PLC) upon activation by extracellular ligands. Once produced, Ins(1,3,5)P3 diffuses through the cytoplasm and binds to its receptors, known as inositol trisphosphate receptors (IP3Rs), which are calcium channels on the ER membrane. Binding of Ins(1,3,5)P3 to IP3Rs induces conformational changes, leading to the opening of the channel pore and subsequent calcium release. This calcium release triggers downstream signaling events mediated by calcium-dependent proteins such as protein kinase C (PKC) and calmodulin. In research, Ins(1,3,5)P3 is widely used to study calcium signaling pathways, investigate its role in cellular physiology, and explain its involvement in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. Researchers employ techniques such as fluorescence imaging, electrophysiology, and biochemical assays to study the dynamics of Ins(1,3,5)P3-mediated calcium signaling and its implications for cellular function and disease pathogenesis.